Meitav Dash Investments »

Intellia Therapeutics shares owned by Meitav Dash Investments

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Meitav Dash Investments from 13F filings

Historical chart of Meitav Dash Investments investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Meitav Dash Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Meitav Dash Investments

Quarter filed Position value Share count Share price at filing
2023-06-30 $465k 14k 33.01

More positions owned by Meitav Dash Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Select Sector Spdr Tr Financial (XLF)
Advanced Micro Devices (AMD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Communication (XLC)
NVIDIA Corporation (NVDA)
Elbit Sys Ord (ESLT)
NOVA MEASURING Instruments L (NVMI)
Vaneck Etf Trust Semiconductr Etf (SMH)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Icl Group SHS (ICL)
Tower Semiconductor Shs New (TSEM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Meitav Dash Investments

Top funds holding Intellia Therapeutics

Vanguard Group
ARK Investment Management
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Nikko Asset Management Americas
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Two Sigma Advisers
FMR

View all funds holding Intellia Therapeutics